Novo-Nordisk A/S (NVO) is a publicly traded Healthcare sector company. As of November 15, 2026, NVO trades at $41.63 with a market cap of $183.52B and a P/E ratio of 0.00. NVO moved +1.94% today. Year to date, NVO is -24.46%; over the trailing twelve months it is -15.32%. Its 52-week range spans $35.12 to $81.44. Analyst consensus is neutral with an average price target of $43.04. Rallies surfaces NVO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Novo-Nordisk A/S (NVO) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. NVO moved +1.94% today. Analyst consensus is neutral.
| Metric | Value |
|---|---|
| Price | $41.63 |
| Market Cap | $183.52B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.58% |
| 52-Week High | $81.44 |
| 52-Week Low | $35.12 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
5 analysts cover NVO: 0 strong buy, 0 buy, 4 hold, 1 sell, 0 strong sell. Consensus rating is neutral. Average price target: $43.04.